Adjuvant therapy in stage II colon cancer: Current approaches

被引：30

作者：

Baddi, L ^{[1
]}

Benson, A ^{[1
]}

机构：

[1] Northwestern Univ, Div Hematol Oncol, Chicago, IL 60611 USA

来源：

ONCOLOGIST | 2005年 / 10卷 / 05期

关键词：

colon cancer; stage II; adjuvant chemotherapy;

D O I：

10.1634/theoncologist.10-5-325

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：325 / 331

页数：7

相关论文

共 28 条

[21] LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF RESECTED COLON-CARCINOMA [J].

MOERTEL, CG ;

FLEMING, TR ;

MACDONALD, JS ;

HALLER, DG ;

LAURIE, JA ;

GOODMAN, PJ ;

UNGERLEIDER, JS ;

EMERSON, WA ;

TORMEY, DC ;

GLICK, JH ;

VEEDER, MH ;

MAILLIARD, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :352-358

[22] FLUOROURACIL PLUS LEVAMISOLE AS EFFECTIVE ADJUVANT THERAPY AFTER RESECTION OF STAGE-III COLON-CARCINOMA - A FINAL REPORT [J].

MOERTEL, CG ;

FLEMING, TR ;

MACDONALD, JS ;

HALLER, DG ;

LAURIE, JA ;

TANGEN, CM ;

UNGERLEIDER, JS ;

EMERSON, WA ;

TORMEY, DC ;

GLICK, JH ;

VEEDER, MH ;

MAILLIARD, JA .

ANNALS OF INTERNAL MEDICINE, 1995, 122 (05) :321-326

[23]

NAUTA R, 1989, ARCH SURG-CHICAGO, V124, P180

[24] Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer [J].

Ribic, CM ;

Sargent, DJ ;

Moore, MJ ;

Thibodeau, SN ;

French, AJ ;

Goldberg, RM ;

Hamilton, SR ;

Laurent-Puig, P ;

Gryfe, R ;

Shepherd, LE ;

Tu, D ;

Redston, M ;

Gallinger, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (03) :247-257

[25] Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer [J].

Schrag, D ;

Rifas-Shiman, S ;

Saltz, L ;

Bach, PB ;

Begg, CB .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (19) :3999-4005

[26] THE BENEFIT OF LEUCOVORIN-MODULATED FLUOROURACIL AS POSTOPERATIVE ADJUVANT THERAPY FOR PRIMARY COLON-CANCER - RESULTS FROM NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL C-03 [J].

WOLMARK, N ;

ROCKETTE, H ;

FISHER, B ;

WICKERHAM, DL ;

REDMOND, C ;

FISHER, ER ;

JONES, J ;

MAMOUNAS, EP ;

ORE, L ;

PETRELLI, NJ ;

SPURR, CL ;

DIMITROV, N ;

ROMOND, EH ;

SUTHERLAND, CM ;

KARDINAL, CG ;

DEFUSCO, PA ;

JOCHIMSEN, P .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1879-1887

[27] Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from national surgical adjuvant breast and bowel project C-04 [J].

Wolmark, N ;

Rockette, H ;

Mamounas, E ;

Jones, J ;

Wieand, S ;

Wickerham, DL ;

Bear, HD ;

Atkins, JN ;

Dimitrov, NV ;

Glass, AG ;

Fisher, ER ;

Fisher, B .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) :3553-3559

[28] ADJUVANT THERAPY OF DUKE-A, DUKE-B, AND DUKE-C ADENOCARCINOMA OF THE COLON WITH PORTAL-VEIN FLUOROURACIL HEPATIC INFUSION - PRELIMINARY-RESULTS OF NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL C-02 [J].

WOLMARK, N ;

ROCKETTE, H ;

WICKERHAM, DL ;

FISHER, B ;

REDMOND, C ;

FISHER, ER ;

POTVIN, M ;

DAVIES, RJ ;

JONES, J ;

ROBIDOUX, A ;

WEXLER, M ;

GORDON, P ;

CRUZ, AB ;

HORSLEY, S ;

NIMS, TA ;

THIRLWELL, M ;

PHILLIPS, WA ;

PRAGER, D ;

STERN, HS ;

LERNER, HJ ;

FRAZIER, TG .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1466-1475